Information on AGM3

Basic details

Name: Agammaglobulinemia 3 | Acronym: AGM3
Alt. names: CD79A deficiency | Ig-alfa deficiency

Gene: CD79A | MOI: Autosomal recessive | Mechanism of action:

No. of cases in DB: 0 | First reported in: 1999

Last updated on: 2023-02-28 16:41:18 by

OMIM: 613501

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

An autosomal recessive form of agammaglobulinemia caused by mutations in the gene CD79A

Management

Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial.

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

0 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 Absence of mature B cellsarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
2 Absent isohemagglutinin levelarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
3 Agammaglobulinemiaarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
4 Diarrheaarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
5 Failure to thrivearrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
6 Infantile onsetarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
7 Neonatal onsetarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
8 Neutropeniaarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
9 repeated bacterial infectionsarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
10 Recurrent bronchitisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
11 Recurrent lower respiratory tract infectionsarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
12 Recurrent otitis mediaarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
13 Abnormal T cell morphologyarrow icon 0 (0.0%) 0 (0.0%) 1 (99.9%)

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.